Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicines Transparency Alliance (MeTA) MeTA FIP 05/09/2009

What is MeTA? An international alliance between: DFID, World Bank, WHO, private sector, NGOs, professional organisations. Alliances in 7 pilot countries to focus on what can be done to increase access to medicines. - Government, CSOs and Private Sector An International Secretariat to support country work, and, upon request, technical assistance. 05/09/2009 MeTA FIP

An international alliance between:

DFID, World Bank, WHO, private sector, NGOs, professional organisations.

Alliances in 7 pilot countries to focus on what can be done to increase access to medicines.

- Government, CSOs and Private Sector

An International Secretariat to support country work, and, upon request, technical assistance.

What does MeTA want to achieve? MeTA goal: to increase access to essential medicines, especially for the poor in developing countries Essential medicines still valid concept But, after 30 years, 2 billion people are still not having access What can we do better? 05/09/2009 MeTA FIP

MeTA goal: to increase access to essential medicines, especially for the poor in developing countries

Essential medicines still valid concept

But, after 30 years, 2 billion people are still not having access

What can we do better?

Added value of MeTA? Country led, bottom-up approach Multi-stakeholder collaboration Improved transparency and disclosure of all players should lead to better information & greater accountability in the supply chain 05/09/2009 MeTA FIP

Country led, bottom-up approach

Multi-stakeholder collaboration

Improved transparency and disclosure of all players should lead to better information & greater accountability in the supply chain

The scope of MeTA Currently 7 countries are piloting MeTA (until September 2010) Global collaboration with private sector, NGOs, donors and professional organisations 05/09/2009 MeTA FIP

Currently 7 countries are piloting MeTA (until September 2010)

Global collaboration with private sector, NGOs, donors and professional organisations

Transparency? Improving information access, scrutiny and use, in order to support the development of viable, efficient medicines markets and supply systems that benefit all developing country consumers Transparency = not only disclosure of the price, quality of medicines; but also: Jointly use the information to identify barriers, and Jointly seek better solutions! MeTA FIP 05/09/2009

Improving information access, scrutiny and use, in order to support the development of viable, efficient medicines markets and supply systems that benefit all developing country consumers

Transparency = not only disclosure of the price, quality of medicines; but also:

Jointly use the information to identify barriers, and

Jointly seek better solutions!

Drug Supply – Transparent? Source: SSDS Inc for the World Bank

Transparent? 05/09/2009 MeTA FIP Source: TI Global corruption report 2006

Areas where transparency can help… 05/09/2009 MeTA FIP Source: TI Global corruption report 2006

Transparency in pharmacy practice? Transparency should be an integral part of Good Pharmacy Practice! Pharmacists can help in both public and private sector Welcome in MeTA! 05/09/2009 MeTA FIP

Transparency should be an integral part of Good Pharmacy Practice!

Pharmacists can help in both public and private sector

Welcome in MeTA!

Contact? Wilbert Bannenberg [email_address] Mobile: +31-6-20873123 MeTA website: www.MedicinesTransparency.org MeTA FIP 05/09/2009

Wilbert Bannenberg

[email_address]

Mobile: +31-6-20873123

MeTA website: www.MedicinesTransparency.org